Gyre Therapeutics (FRA:L9S) FFO


FRA:L9S Gyre Therapeutics Inc FRA:L9S
43 GF Score
Price €5.95
GF Value €8.44
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Gyre Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:L9S
43GF Score
Gyre Therapeutics Inc FRA:L9S
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gyre Therapeutics (FRA:L9S) Overvalued in 2026?

Based on GuruFocus' analysis, Gyre Therapeutics stock appears to be undervalued. The current stock price of €5.95 is trading 29.5% below its estimated GF Value™ of €8.44. GuruFocus considers Gyre Therapeutics to be Significantly Undervalued.

Key valuation signals for FRA:L9S:

  • FFO:
  • GF Value™: €8.44 vs. price of €5.95 (29.5% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the FRA:L9S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gyre Therapeutics Business Description

Other Exchanges GYRE:USA
Address 12770 High Bluff Drive, Suite 150, San Diego, CA, USA, 92130
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
43GF Score

Get the complete analysis for FRA:L9S

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.95
Price
€8.44
GF Value